Clinical Data, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Clinical Data, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Clinical Data, Inc.. The Group's principal activity is to focus on the development and commercialization of targeted therapeutics and predictive tests, and to provide world-leading value-based genomic solutions to both the healthcare and life sciences industries. The Group operates business in two segments: PGxHealth and Cogenics. It operates in the United States, North America, Europe, Asia and Other foreign countries. The Group also acquired Epidauros Biotechnologie A.G. last August 23, 2007.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report